Lisa Lancaster, PharmD

Associate Professor of Medicine
Division of Allergy, Pulmonary, and Critical Care Medicine

Vanderbilt University Medical Center

Dr. Lisa Lancaster is an Associate Professor of Medicine at Vanderbilt University Medical Center and has extensive experience with clinical management and research in Idiopathic Pulmonary Fibrosis (IPF). Idiopathic Pulmonary Fibrosis is a progressive scarring lung disease of unknown etiology. More than 40,000 new cases of IPF are diagnosed each year, usually later in life between the ages of 50 and 70. Two new therapies that slow disease progression but do not cure disease have been identified. Extensive research is going on nationally and internationally to find a cure for this disease. Dr. Lancaster serves as the medical director of the Interstitial Lung Disease /Idiopathic Pulmonary Fibrosis Program and Clinical Trials Center that was a part of an 11-center IPF network of the National Institutes of Health. Under Dr. Lancaster’s direction from 1999 to present, the Center has grown from one active clinical study to over 65 multi-center international pharmaceutical and NIH active and inactive studies and is recognized as a leading IPF clinical trials center nationally and internationally.

Asembia

200 Park Avenue, Suite 300 
Florham Park, NJ 07932

973.564.8004

asembia.com

info@asembiasummit.com

SIGN UP FOR SUMMIT UPDATES

Asembia's Specialty Pharmacy Summit is a PRIVATE EVENT. Asembia reserves the right to deny registration and refuse access at our absolute and sole discretion for any reason whatsoever.

© 2020 Asembia Specialty Pharmacy Summit, LLC. All rights reserved.

CONNECT WITH US

  • Asembia LinkedIn
  • Asembia Twitter
  • Asembia Instagram
  • Asembia Facebook
  • Asembia Videos
  • Asembia Photos
2021Summit_Logo_White.png